Bitcoin Fuels Gray-Market Peptide Boom as Banks Avoid Unregulated Compounds

The growing demand for peptides has led to an influx of cryptocurrency payments in the gray market. In the first quarter of 2026, peptide vendors received $32 million in Bitcoin, a 700% increase from the same period last year.

Banks and card networks often reject merchants selling unapproved compounds due to legal and regulatory risks, forcing some suppliers to accept only cryptocurrency payments. This has drawn first-time crypto users into an unregulated market for experimental wellness compounds.

Zach, a 49-year-old marketing director, bought 20 vials of purported retatrutide from a Chinese seller for $240 in Bitcoin, despite concerns about the speculative asset's price volatility.

Sara Graham, a senior intelligence analyst at Chainalysis, said the market is attracting first-time crypto buyers with no darknet market history. The sector is on pace to exceed $100 million annually, with recent activity putting it on track to become one of the world's fastest-growing drug markets.